 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN.

Watchers	4,885
52-Wk Low	$0.00
52-Wk High	$0.00

Market Cap	$0.00
Volume (M)	2.34M
52-Wk High	$0.00
52-Wk Low	$0.00

ECYT Endocyte, Inc.

About

Feed

News

Fundamentals

Latest ECYT News